Email Page Print Page

SEC Filings and Financial Information

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQBDSI
FormDescriptionDateFormat
SC 13D/AAmendment to a SC 13D filingDec 10, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventDec 9, 2010View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderDec 8, 2010View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventNov 23, 2010View HTMLDownload DOCDownload PDFDownload XLS
10-K/AAmendment to a previously filed 10-KNov 19, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventNov 12, 2010View HTMLDownload DOCDownload PDFDownload XLS
10-QQuarterly report which provides a continuing view of a company's financial positionNov 9, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 27, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventOct 8, 2010View HTMLDownload DOCDownload PDFDownload XLS
3Initial filing by director officer or owner of more than ten percent.Sep 17, 2010View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 7, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventSep 2, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 26, 2010View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionAug 9, 2010View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventJul 23, 2010View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 23, 2010View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 23, 2010View HTMLDownload DOCDownload PDF
CT ORDERConfidential treatment orderJun 25, 2010View HTMLDownload DOCDownload PDF
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Jun 18, 2010View HTMLDownload DOCDownload PDFDownload XLS
1-25      26-44
Top News
Oct 12, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that it has entered into a...

Oct 6, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) participated in a round table meeting convened this week in Washington, D.C. by the U.S. Department of Health and Human Services (HHS) to...

Sep 19, 2017

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, Vice Chairman, President and Chief Executive Officer, will present at two upcoming healthcare conferences....

investor inquiries

 

Al Medwar
Senior Vice President, Corporate and Business Development
BioDelivery Sciences International, Inc.
919-582-9050
amedwar@bdsi.com